He is talking about security and privacy. But he might just as easily be describing the quiet conviction — held now by a ...

Feb 23 (Reuters) - Drug developer Generate Biomedicines said on Monday it was targeting a valuation of up to $2.17 billion its initial public offering in the United States. The Somerville, ...

AI safety tests found to rely on 'obvious' trigger words; with easy rephrasing, models labeled 'reasonably safe' suddenly fail, with attacks succeeding up to 98% of the time. New corporate research ...

Sasha Stiles turned GPT-2 experiments into a self-writing poem at a Museum of Modern Art installation—and a new way to think about text-generating AI optimization ...